And now instead of silence, investors who go to do some DD on Resverlogix, they're going to be reading about a company:
- that just received a big investment from a leading Chinese Pharma Co,
- about a company that just retired its debt
- about a company being called one Canada's most undervalued Biotechs
And all of this is new and fresh, not a stale dated PR from 3 months ago.